Skip to main content
See every side of every news story
Published • loading... • Updated

Abbott Laboratories (NYSE: ABT), AbbVie (NYSE: ABBV), And Coca-Cola (NYSE: KO) Stand Out As Elite Dividend Compounders Built To Last

Abbott Laboratories (NYSE: ABT) made headlines this year after closing a $21 billion cash deal to acquire Exact Sciences, a company focused on cancer diagnostics. The acquisition targets one of Abbott’s slower-growing business units and signals a strategic push to strengthen its diagnostic capabilities in an increasingly competitive healthcare market. Abbott also leads the continuous […]
DisclaimerRead with caution - this story is only being covered by one news source that has a ‘low factuality’ rating, which means the outlet has a history of poor reporting practices. Learn more about factuality ratings here.

Bias Distribution

  • 100% of the sources lean Left
100% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

foreignpolicyjournal.com broke the news on Thursday, November 19, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal